Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy.

Baumann, Daniel; Offringa, Rienk

Baumann, Daniel; Offringa, Rienk.

Afiliación

Baumann D; Department of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center Heidelberg, Heidelberg, Baden-Wuerttemberg, 69120, Germany.
Offringa R; Department of Surgery, Heidelberg University Hospital, Heidelberg, Baden-Wuerttemberg, 69120, Germany.

Cell Stress ; 4(10): 248-251, 2020 Aug 06.

Article en En | MEDLINE | ID: mdl-33024933

Palabras clave

CD40; MAPK; MEK inhibition; agonist; cancer immunotherapy; combinatorial immunotherapy; cytostatic agents; immune checkpoint blockade; immunogenic cell death

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cell Stress Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Austria

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google